Optimization of Purification Technology for Shenqi Sherong Pills by Chemical and Pharmacodynamic Indicators
|更新时间:2024-01-04
|
Optimization of Purification Technology for Shenqi Sherong Pills by Chemical and Pharmacodynamic Indicators
Chinese Journal of Experimental Traditional Medical FormulaeVol. 19, Issue 6, Pages: 36-39(2013)
作者机构:
作者简介:
基金信息:
DOI:
CLC:
Published:2013
稿件说明:
移动端阅览
ZHOU Yong-quan, LIU Shu-fen, ZHANG Ning, et al. Optimization of Purification Technology for Shenqi Sherong Pills by Chemical and Pharmacodynamic Indicators[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(6): 36-39.
DOI:
ZHOU Yong-quan, LIU Shu-fen, ZHANG Ning, et al. Optimization of Purification Technology for Shenqi Sherong Pills by Chemical and Pharmacodynamic Indicators[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(6): 36-39.DOI:
Optimization of Purification Technology for Shenqi Sherong Pills by Chemical and Pharmacodynamic Indicators
Objective: To optimize purification technology conditions of Shenqi Sherong prescription. Method: With the content of astragaloside Ⅳ as chemical index
while BBB score and pathological section of rats after spinal cord injuried and toe swelling rate as pharmacodynamic indexes
purification technology of water extract from Shenqi Sherong prescription was optimized according to the above mentioned indexes. Result: Optimized purification conditions was as following:after concentrated
water extract was added alcohol until the alcohol content of 60%. Conclusion: Purification technologies for water extract of Shenqi Sherong prescription had consistency by screening chemical index and pharmacodynamics indexes
it could provide experimental basis for guaranteeing quality of Shenqi Sherong prescription.
Analysis of Mechanism of Astragaloside Ⅳ in Regulating Ferroptosis Through SLC7A11/GPX4 Pathway Against Vascular Smooth Muscle Cell Proliferation
Mechanism of Astragaloside Ⅳ in Regulating PI3K/Akt Molecular Pathway in Prevention and Treatment of Diabetes Complications: A Review
Molecular Mechanism of Action of Astragaloside Ⅳ in Modulating Pyroptosis to Attenuate Intestinal Ischemia-reperfusion Injury Based on Experimental Validation
Mechanism of Astragaloside Ⅳ on db/db Mice with Type 2 Diabetes Mellitus and Non-alcoholic Fatty Liver Disease Based on AMPK Signaling Pathway
Astragaloside Ⅳ Induces Autophagy and Apoptosis in Nasopharyngeal Carcinoma Cells via PI3K/Akt/mTOR Pathway
Related Author
LI Guoting
YANG Changchao
LIU Lin
LI Weikang
ZHAO Zixian
SHEN Quan
ZHAO Jingshan
HU Kexin
Related Institution
Hebei Key Laboratory of Traditional Chinese Medicine(TCM) Research on Cardiocerebrovascular Disease,TCM Processing Technology Innovation Center of Hebei Province,College of Pharmacy, Hebei University of Chinese Medicine
Key Laboratory of Xin'an Medical Education Department,Anhui University of Chinese Medicine
The First Affiliated Hospital of Anhui University of Chinese Medicine